×
About 51,870 results

ALLMedicine™ Bipolar Disorder Center

Research & Reviews  23,861 results

Magnitude and variability of structural brain abnormalities in neuropsychiatric disease...
https://doi.org/10.1136/ebmental-2020-300229
Evidence-based Mental Health; McCutcheon R, Pillinger T et. al.

Apr 14th, 2021 - Structural MRI is the most frequently used method to investigate brain volume alterations in neuropsychiatric disease. Previous meta-analyses have typically focused on a single diagnosis, thereby precluding transdiagnostic comparisons. We will inc...

Grey and white matter alteration in euthymic children with bipolar disorder: a combined...
https://doi.org/10.1007/s11682-021-00473-0
Brain Imaging and Behavior; Singh A, Arya A et. al.

Apr 13th, 2021 - Bipolar disorder (BPD) is a psychiatric condition driving frequent mood swings between periodic extremes of happiness and depression in patients. In this study, a source-based morphometry (SBM) and voxel-based morphometry (VBM) analysis was utiliz...

Aripiprazole IM depot as an option for the treatment of bipolar disorder.
https://doi.org/10.1080/14656566.2021.1910236
Expert Opinion on Pharmacotherapy; Kotzalidis GD, Rapinesi C et. al.

Apr 13th, 2021 - Introduction: Long-acting injectable (LAI) antipsychotic drugs are developed to reduce daily intake need and to overcome treatment non-adherence. Aripiprazole IM depot refers to two long-acting aripiprazole formulations, once monthly monohydrate (...

Evidence for avolition in bipolar disorder? A 30-day ecological momentary assessment co...
https://doi.org/10.1016/j.psychres.2021.113924
Psychiatry Research; Strassnig MT, Miller ML et. al.

Apr 13th, 2021 - Disability is common in bipolar disorder (BD) and predicted by persistent sadness. We used ecological momentary assessment (EMA) to examine daily activities in people with BD and schizophrenia. We classified activities as productive, unproductive,...

Differentiation of bipolar disorder versus borderline personality disorder: A machine l...
https://doi.org/10.1016/j.jad.2021.03.082
Journal of Affective Disorders; Bayes A, Spoelma MJ et. al.

Apr 12th, 2021 - Differentiation of bipolar disorder (BP) from borderline personality disorder (BPD) is a common diagnostic dilemma. We undertook a machine learning (ML) approach to distinguish the conditions. Participants meeting DSM criteria for BP or BPD were c...

see more →

Guidelines  65 results

Nightmares in Patients with Major Depressive Disorder, Bipolar Disorder, and Psychotic Disorders: A Systematic Review
https://pubmed.ncbi.nlm.nih.gov/33317105/
Journal of Clinical Medicine; Akkaoui MA

Dec 8th, 2020 - Chronic nightmares are very common in psychiatric disorders, affecting up to 70% of patients with personality or post-traumatic stress disorders. In other psychiatric disorders, the relationships with nightmares are poorly known. This review aimed...

Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar Depression
https://www.allergan.com/news/news/thomson-reuters/allergan-and-gedeon-richter-receive-u-s-fda-approv.aspx

May 27th, 2019 - Allergan plc (NYSE: AGN) and Gedeon Richter Plc. today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for VRAYLAR® (cariprazine) for expanded use to treat depressive episodes ass...

EPA guidance on physical activity as a treatment for severe mental illness: a meta-revi...
https://doi.org/10.1016/j.eurpsy.2018.07.004
European Psychiatry : the Journal of the Association of E... Stubbs B, Vancampfort D et. al.

Sep 27th, 2018 - Physical activity (PA) may be therapeutic for people with severe mental illness (SMI) who generally have low PA and experience numerous life style-related medical complications. We conducted a meta-review of PA interventions and their impact on he...

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
https://onlinelibrary.wiley.com/doi/epdf/10.1111/bdi.12609
Yatham,L.,et al

Apr 20th, 2018 - The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously pub-lished treatment guidelines for bipolar disorder in 2005, along with international com-mentaries and subsequent updates in 2007, 2009, and 2013. The last two updates were...

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947163
Bipolar Disorders; Yatham LN, Kennedy SH et. al.

Mar 14th, 2018 - The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published treatment guidelines for bipolar disorder in 2005, along with international commentaries and subsequent updates in 2007, 2009, and 2013. The last two updates were p...

see more →

Drugs  953 results see all →

Clinicaltrials.gov  25,541 results

Magnitude and variability of structural brain abnormalities in neuropsychiatric disease...
https://doi.org/10.1136/ebmental-2020-300229
Evidence-based Mental Health; McCutcheon R, Pillinger T et. al.

Apr 14th, 2021 - Structural MRI is the most frequently used method to investigate brain volume alterations in neuropsychiatric disease. Previous meta-analyses have typically focused on a single diagnosis, thereby precluding transdiagnostic comparisons. We will inc...

Grey and white matter alteration in euthymic children with bipolar disorder: a combined...
https://doi.org/10.1007/s11682-021-00473-0
Brain Imaging and Behavior; Singh A, Arya A et. al.

Apr 13th, 2021 - Bipolar disorder (BPD) is a psychiatric condition driving frequent mood swings between periodic extremes of happiness and depression in patients. In this study, a source-based morphometry (SBM) and voxel-based morphometry (VBM) analysis was utiliz...

Aripiprazole IM depot as an option for the treatment of bipolar disorder.
https://doi.org/10.1080/14656566.2021.1910236
Expert Opinion on Pharmacotherapy; Kotzalidis GD, Rapinesi C et. al.

Apr 13th, 2021 - Introduction: Long-acting injectable (LAI) antipsychotic drugs are developed to reduce daily intake need and to overcome treatment non-adherence. Aripiprazole IM depot refers to two long-acting aripiprazole formulations, once monthly monohydrate (...

Evidence for avolition in bipolar disorder? A 30-day ecological momentary assessment co...
https://doi.org/10.1016/j.psychres.2021.113924
Psychiatry Research; Strassnig MT, Miller ML et. al.

Apr 13th, 2021 - Disability is common in bipolar disorder (BD) and predicted by persistent sadness. We used ecological momentary assessment (EMA) to examine daily activities in people with BD and schizophrenia. We classified activities as productive, unproductive,...

Differentiation of bipolar disorder versus borderline personality disorder: A machine l...
https://doi.org/10.1016/j.jad.2021.03.082
Journal of Affective Disorders; Bayes A, Spoelma MJ et. al.

Apr 12th, 2021 - Differentiation of bipolar disorder (BP) from borderline personality disorder (BPD) is a common diagnostic dilemma. We undertook a machine learning (ML) approach to distinguish the conditions. Participants meeting DSM criteria for BP or BPD were c...

see more →

News  1,403 results

No More Excuses: Vaccine Trials Prove Clinical Trial Diversity Is Doable
https://www.medscape.com/viewarticle/945400

Feb 9th, 2021 - The increased representation of minority patients in the COVID vaccine trials puts the rest of medicine to shame. For decades there have been calls to make clinical trials more diverse, but the 2015-2019 Drug Trials Snapshots Summary Report by the...

Billions of Years Old, Lithium Still Has a Promising Therapeutic Future
https://www.medscape.com/viewarticle/944226

Jan 14th, 2021 - In a six-decade career spent researching and prescribing lithium ― a long-established therapy for bipolar disorder ― psychiatrist David Dunner, MD, has many stories about the treatment's fraught path to mainstream acceptance and the schism it caus...

Lithium Resistance in Bipolar Tied to Deficient Gene Expression
https://www.medscape.com/viewarticle/944051

Jan 12th, 2021 - A decrease in activation of a specific gene may explain why many patients with bipolar disorder (BD) do not respond to lithium, new research suggests. Although lithium is considered to be the "gold standard" for treating the disorder, almost 70% o...

Global Experts Map the Latest in Bipolar Management
https://www.medscape.com/viewarticle/942903

Dec 17th, 2020 - A new monograph offers a far-reaching update on research and clinical management of bipolar disorders (BDs), including epidemiology, genetics, pathogenesis, psychosocial aspects, and current and investigational therapies. "I regard this as a 'glob...

Nightmares in Patients with Major Depressive Disorder, Bipolar Disorder, and Psychotic Disorders: A Systematic Review
https://pubmed.ncbi.nlm.nih.gov/33317105/
Journal of Clinical Medicine; Akkaoui MA

Dec 8th, 2020 - Chronic nightmares are very common in psychiatric disorders, affecting up to 70% of patients with personality or post-traumatic stress disorders. In other psychiatric disorders, the relationships with nightmares are poorly known. This review aimed...

see more →

Patient Education  47 results see all →